Megi
Megi is an AI-driven platform delivering personalized heart care for women, beginning in pregnancy and continuing lifelong, ensuring proactive support, prevention, and guidance to protect women’s heart health at every stage.
About Megi
Megi is an AI-powered platform dedicated to providing personalized heart care for women, beginning during pregnancy and extending through long-term cardiovascular support. By identifying risks early and guiding women at every stage of care, Megi helps prevent pregnancy-related complications such as preeclampsia while also supporting ongoing cardiovascular disease (CVD) prevention and management. Through data-driven insights and tailored care pathways, Megi empowers women and healthcare providers to improve outcomes, promote heart health, and deliver proactive, personalized care across a woman’s life.
Recently Added Startups
Tacalyx
Tacalyx creates medications that target carbohydrate antigens unique to cancer on the surface of metastatic malignant tumors for which there are no effective treatments.
We Travel Hub
We Travel Hub is a tourism-focused affiliate platform connecting travelers, content creators, merchants, and advertisers, featuring Travelfinder to monetize travel content and streamline bookings.
FrontWave Imaging
FrontWave Imaging develops supercomputing software that aids in breast cancer diagnosis. Barcelona Supercomputing Center is the parent company of Frontwave Imaging S.L.
Healthtech
Arjuna Therapeutics
ARJUNA Therapeutics develops a novel class of orally available small molecules aimed at treating currently untreatable cancers, making cancer more survivable.
UNAVETS
UNAVETS Group is one of the largest veterinary healthcare groups in the Iberian Peninsula, operating an extensive network of clinics and hospitals.